SCHEMBL165360

SCHEMBL165360

[Li][Si](C)(C)N(C)[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7266312 0.74
SCHEMBL234175 0.74
SCHEMBL8613099 0.61
SCHEMBL22589614 0.61 ALDH1A1 (0.36)
SCHEMBL318716 0.61
SCHEMBL2709128 0.61 ALDH1A1 (0.36)
SCHEMBL986125 0.61
SCHEMBL22589391 0.61
SCHEMBL1768149 0.61
SCHEMBL2924601 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 243 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4028396-B1 PROCESS FOR THE PREPARATION OF A MEDICAMENT CONTAINING AN OXEPANE RING. HOFFMANN LA ROCHE (CH) 2024-01-03 EP claimed
EP-3902786-B1 PREPARATION OF SULFONAMIDE HERBICIDE PROCESS INTERMEDIATES CORTEVA AGRISCIENCE LLC (US) 2022-12-14 EP claimed
EP-3303362-B1 IMPROVED PROCESSES FOR THE PREPARATION OF SOFOSBUVIR AND INTERMEDIATES THEREOF TEVA PHARMACEUTICALS INT GMBH (CH) 2022-10-19 EP claimed
EP-2488522-B1 NOVEL METHOD FOR PREPARING ENTECAVIR AND INTERMEDIATE USED THEREIN HANMI SCIENCE CO LTD (KR) 2017-02-15 EP claimed
EP-1807408-B1 OXY SUBSTITUTED FLAVONES AS ANTIHYPERGLYCEMIC AND ANTIDYSLIPIDEMIC AGENTS COUNCIL SCIENT IND RES (IN) 2016-06-08 EP claimed
EP-2134681-B1 TRANS-ANNULAR REARRANGEMENT OF ACTIVE LACTAMES CENTRE NAT RECH SCIENT (FR) 2012-05-16 EP claimed
EP-1995815-B1 Electrolytic organic glass, process for the production thereof and device comprising the same COMMISSARIAT ENERGIE ATOMIQUE (FR) 2010-12-08 EP claimed
EP-1951695-B1 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1 AMGEN INC (US) 2009-12-23 EP claimed
EP-1368325-B1 NEW ASYMMETRIC PROCESS FOR THE PREPARATION OF DIARYLMETHYLPIPERAZINES DERIVATIVES AND NOVEL ASYMMETRIC DIARYLMETYLAMINES AS INTERMEDIATES ASTRAZENECA AB (SE) 2008-08-27 EP claimed
EP-1937673-A1 IMIDAZOLE DERIVATIVES AS INHIBITORS OF TAFIA Sanofi-Aventis (FR) 2008-07-02 EP claimed
WO-2007045339-A1 IMIDAZOLE DERIVATIVES AS INHIBITORS OF TAFIA SANOFI-AVENTIS (DE) 2007-04-26 WO claimed
EP-1403271-B1 Method of producing 5-formyl-2-furylboronic acid DEGUSSA (DE) 2005-11-16 EP claimed
EP-0628030-B1 2,3,4,5-TETRAHYDRO-1H --3-BENZAZEPINES HAVING ANTI-PSYCHOTIC ACTIVITY, AND SYNTHESIS OF $g(a)-SUBSTITUTED-ARYLACETAMIDES SCHERING CORP (US) 2002-12-11 EP claimed
EP-1008583-B1 Process for making 2-alkyl-3-hydroxybenzoic acids DOW AGROSCIENCES LLC (US) 2002-10-09 EP claimed
EP-0525880-B1 Catalytic alkylation process FMC CORP (US) 1998-05-06 EP claimed
EP-0209352-B1 PROCESS AND INTERMEDIATES FOR BETA-LACTAM ANTIBIOTICS THE PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1991-05-02 EP claimed
EP-0045524-B1 22-ARYLSULFONYL-24,25-DIHYDROXYCHOLESTANES AND PROCESS FOR PREPARING THE SAME Chugai Seiyaku Kabushiki Kaisha (JP) 1983-10-19 EP claimed
EP-3994134-B9 PROCESS FOR MANUFACTURING (S)-3-HYDROXY-1-(1H-INDOL-5-YL)-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID 3,5-DIFLUORO-BENZYLAMIDE MERCK PATENT GMBH (DE) 2024-06-26 EP disclosed
EP-0145441-A2 Alpha-aminoboronic acid peptides E.I. DU PONT DE NEMOURS AND COMPANY (US) 1985-06-19 EP disclosed
US-4499082-A INHIBITORS OF PROTEOLYTIC ENZYMES E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-02-12 US disclosed